BioTwin’s C$2.5 Million Financing Round

Fasken advised BioTwin in connection with this transaction.On April 8, 2021, BioTwin, a Quebec-based biotechnology company, announced the completion of their pre-seed funding round. The company…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here